Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Mark S. Lesney, PhD

  • News

    Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections

    January 29, 2021

    The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.

  • 1
    News

    Eliminating hepatitis by 2030: HHS releases new strategic plan

    January 14, 2021

    The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”

  • News

    Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?

    November 10, 2020

    Environmental pollution during the COVID-19 pandemic puts dolphins, whales, seals, and otters among the sea mammals at risk.

  • 1
    Article

    Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate

    October 20, 2020

    Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival, comparable with the general population.

  • News

    Blood group O linked to decreased risk of SARS-CoV-2 infection

    October 15, 2020

    A retrospective analysis of all Danish individuals with a known ABO blood group tested for SARS-CoV-2 showed a lower infection risk for SARS-CoV-2 infection in blood group O.

  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences